MARKETS
Markets

Helus Pharma Appoints Michael Halstead CEO, Effective Immediately

Aug 3, 2026 · 07:44 AM ET· updated 3h ago

Helus Pharma (NASDAQ:HELP) (Cboe CA: HELP) (the "Company" or "Helus Pharma"), a clinical-stage pharmaceutical company committed to helping minds heal by developing novel serotonergic agonists

Share
Why It Matters

Helus Pharma picked a new leader named Michael Halstead to run the company. When a company changes its top boss, watch to see if the new leader has good ideas for making medicines and if people trust him to do the job well.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.